Robust changes in expression of brain-derived neurotrophic factor (BDNF) mRNA and protein across the brain do not translate to detectable changes in BDNF levels in CSF or plasma

References

• Alonso P, Gratacòs M, Menchón JM, Saiz-Ruiz J, Segalàs C, Baca-García E, Labad J, Fernández-Piqueras J, Real E, Vaquero C, Pérez M, Dolengevich H, González JR, Bayés M, de Cid R, Vallejo J, Estivill X. (2008). Extensive genotyping of the BDNF and NTRK2 genes define protective haplotypes against obsessive-compulsive disorder. Biol Psychiatry 63:619–628.
   PubMed Web of Science ®Google Scholar
• Angelucci F, Spalletta G, di Iulio F, Ciaramella A, Salani F, Colantoni L, Varsi AE, Gianni W, Sancesario G, Caltagirone C, Bossù P. (2010). Alzheimer’s disease (AD) and Mild Cognitive Impairment (MCI) patients are characterized by increased BDNF serum levels. Curr Alzheimer Res 7:15–20.
   PubMed Web of Science ®Google Scholar
• Balkowiec A, Katz DM. (2000). Activity-dependent release of endogenous brain-derived neurotrophic factor from primary sensory neurons detected by ELISA in situ. J Neurosci 20:7417–7423.
   PubMed Web of Science ®Google Scholar
• Barbosa IG, Huguet RB, Mendonça VA, Neves FS, Reis HJ, Bauer ME, Janka Z, Palotás A, Teixeira AL. (2010). Increased plasma levels of brain-derived neurotrophic factor in patients with long-term bipolar disorder. Neurosci Lett 475:95–98.
   PubMed Web of Science ®Google Scholar
• Barker JL, Dufy B, Harrison NL, Owen DG, MacDonald JF. (1987). Signal transduction mechanisms in cultured CNS neurons and clonal pituitary cells. Neuropharmacology 26:941–955.
   PubMed Web of Science ®Google Scholar
• Ben-Ari Y, Tremblay E, Riche D, Ghilini G, Naquet R. (1981). Electrographic, clinical and pathological alterations following systemic administration of kainic acid, bicuculline or pentetrazole: Metabolic mapping using the deoxyglucose method with special reference to the pathology of epilepsy. Neuroscience 6:1361–1391.
   PubMed Web of Science ®Google Scholar
• Canals JM, Pineda JR, Torres-Peraza JF, Bosch M, Martín-Ibañez R, Muñoz MT, Mengod G, Ernfors P, Alberch J. (2004). Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington’s disease. J Neurosci 24:7727–7739.
   PubMed Web of Science ®Google Scholar
• Capelle HH, Weigel R, Schmelz M, Krauss JK. (2009). Neurotrophins in the cerebrospinal fluid of patient cohorts with neuropathic pain, nociceptive pain, or normal pressure hydrocephalus. Clin J Pain 25:729–733.
   PubMed Web of Science ®Google Scholar
• Chen Y, Stevens B, Chang J, Milbrandt J, Barres BA, Hell JW. (2008). NS21: Re-defined and modified supplement B27 for neuronal cultures. J Neurosci Methods 171:239–247.
   PubMed Web of Science ®Google Scholar
• Chen ZY, Jing D, Bath KG, Ieraci A, Khan T, Siao CJ, Herrera DG, Toth M, Yang C, McEwen BS, Hempstead BL, Lee FS. (2006). Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314:140–143.
   PubMed Web of Science ®Google Scholar
• Connor B, Young D, Yan Q, Faull RL, Synek B, Dragunow M. (1997). Brain-derived neurotrophic factor is reduced in Alzheimer’s disease. Brain Res Mol Brain Res 49:71–81.
   PubMedGoogle Scholar
• Cowansage KK, LeDoux JE, Monfils MH. (2010). Brain-derived neurotrophic factor: A dynamic gatekeeper of neural plasticity. Curr Mol Pharmacol 3:12–29.
   PubMedGoogle Scholar
• Dong M, Wu Y, Fan Y, Xu M, Zhang J. (2006). c-fos modulates brain-derived neurotrophic factor mRNA expression in mouse hippocampal CA3 and dentate gyrus neurons. Neurosci Lett 400:177–180.
   PubMed Web of Science ®Google Scholar
• Dugich-Djordjevic MM, Tocco G, Lapchak PA, Pasinetti GM, Najm I, Baudry M, Hefti F. (1992). Regionally specific and rapid increases in brain-derived neurotrophic factor messenger RNA in the adult rat brain following seizures induced by systemic administration of kainic acid. Neuroscience 47:303–315.
   PubMed Web of Science ®Google Scholar
• Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN. (2003). Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 60:804–815.
   PubMed Web of Science ®Google Scholar
• Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR. (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112:257–269.
   PubMed Web of Science ®Google Scholar
• Evans RH. (1986). Pharmacology of amino acid receptors on vertebrate primary afferent nerve fibres. Gen Pharmacol 17:5–11.
   PubMedGoogle Scholar
• Ferrer I, Goutan E, Marín C, Rey MJ, Ribalta T. (2000). Brain-derived neurotrophic factor in Huntington disease. Brain Res 866:257–261.
   PubMed Web of Science ®Google Scholar
• Ferrer I, Krupinski J, Goutan E, Martí E, Ambrosio S, Arenas E. (2001). Brain-derived neurotrophic factor reduces cortical cell death by ischemia after middle cerebral artery occlusion in the rat. Acta Neuropathol 101:229–238.
   PubMed Web of Science ®Google Scholar
• Hock C, Heese K, Hulette C, Rosenberg C, Otten U. (2000). Region-specific neurotrophin imbalances in Alzheimer disease: Decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch Neurol 57:846–851.
   PubMed Web of Science ®Google Scholar
• Katoh-Semba R, Takeuchi IK, Inaguma Y, Ito H, Kato K. (1999). Brain-derived neurotrophic factor, nerve growth and neurotrophin-3 selected regions of the rat brain following kainic acid-induced seizure activity. Neurosci Res 35:19–29.
   PubMed Web of Science ®Google Scholar
• Klein R, Conway D, Parada LF, Barbacid M. (1990). The trkB tyrosine protein kinase gene codes for a second neurogenic receptor that lacks the catalytic kinase domain. Cell 61:647–656.
   PubMed Web of Science ®Google Scholar
• Laske C, Stransky E, Leyhe T, Eschweiler GW, Maetzler W, Wittorf A, Soekadar S, Richartz E, Koehler N, Bartels M, Buchkremer G, Schott K. (2007). BDNF serum and CSF concentrations in Alzheimer’s disease, normal pressure hydrocephalus and healthy controls. J Psychiatr Res 41:387–394.
   PubMed Web of Science ®Google Scholar
• Leverenz JB, Watson GS, Shofer J, Zabetian CP, Zhang J, Montine TJ. (2011). Cerebrospinal fluid biomarkers and cognitive performance in non-demented patients with Parkinson’s disease. Parkinsonism Relat Disord 17:61–64.
   PubMed Web of Science ®Google Scholar
• Li G, Peskind ER, Millard SP, Chi P, Sokal I, Yu CE, Bekris LM, Raskind MA, Galasko DR, Montine TJ. (2009). Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects. PLoS ONE 4:e5424.
   PubMed Web of Science ®Google Scholar
• Mannari C, Origlia N, Scatena A, Del Debbio A, Catena M, Dell’agnello G, Barraco A, Giovannini L, Dell’osso L, Domenici L, Piccinni A. (2008). BDNF level in the rat prefrontal cortex increases following chronic but not acute treatment with duloxetine, a dual acting inhibitor of noradrenaline and serotonin re-uptake. Cell Mol Neurobiol 28:457–468.
   PubMed Web of Science ®Google Scholar
• Nagahara AH, Merrill DA, Coppola G, Tsukada S, Schroeder BE, Shaked GM, Wang L, Blesch A, Kim A, Conner JM, Rockenstein E, Chao MV, Koo EH, Geschwind D, Masliah E, Chiba AA, Tuszynski MH. (2009). Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer’s disease. Nat Med 15:331–337.
   PubMed Web of Science ®Google Scholar
• Ochs G, Penn RD, York M, Giess R, Beck M, Tonn J, Haigh J, Malta E, Traub M, Sendtner M, Toyka KV. (2000). A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:201–206.
   PubMed Web of Science ®Google Scholar
• Parain K, Murer MG, Yan Q, Faucheux B, Agid Y, Hirsch E, Raisman-Vozari R. (1999). Reduced expression of brain-derived neurotrophic factor protein in Parkinson’s disease substantia nigra. Neuroreport 10:557–561.
   PubMed Web of Science ®Google Scholar
• Pezawas L, Verchinski BA, Mattay VS, Callicott JH, Kolachana BS, Straub RE, Egan MF, Meyer-Lindenberg A, Weinberger DR. (2004). The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 24:10099–10102.
   PubMed Web of Science ®Google Scholar
• Pezet S, Malcangio M. (2004). Brain-derived neurotrophic factor as a drug target for CNS disorders. Expert Opin Ther Targets 8:391–399.
   PubMed Web of Science ®Google Scholar
• Pillai A, Kale A, Joshi S, Naphade N, Raju MS, Nasrallah H, Mahadik SP. (2010). Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: Correlation with plasma BDNF and psychopathology. Int J Neuropsychopharmacol 13:535–539.
   PubMed Web of Science ®Google Scholar
• Racine RJ. (1972). Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32:281–294.
   PubMedGoogle Scholar
• Rosas-Vargas H, Martínez-Ezquerro JD, Bienvenu T. (2011). Brain-derived neurotrophic factor, food intake regulation, and obesity. Arch Med Res 42:482–494.
   PubMed Web of Science ®Google Scholar
• Rudge JS, Mather PE, Pasnikowski EM, Cai N, Corcoran T, Acheson A, Anderson K, Lindsay RM, Wiegand SJ. (1998). Endogenous BDNF protein is increased in adult rat hippocampus after a kainic acid induced excitotoxic insult but exogenous BDNF is not neuroprotective. Exp Neurol 149:398–410.
   PubMed Web of Science ®Google Scholar
• Rybakowski JK. (2008). BDNF gene: Functional Val66Met polymorphism in mood disorders and schizophrenia. Pharmacogenomics 9:1589–1593.
   PubMed Web of Science ®Google Scholar
• Salehi Z, Mashayekhi F. (2009). Brain-derived neurotrophic factor concentrations in the cerebrospinal fluid of patients with Parkinson’s disease. J Clin Neurosci 16:90–93.
   PubMed Web of Science ®Google Scholar
• Santi S, Cappello S, Riccio M, Bergami M, Aicardi G, Schenk U, Matteoli M, Canossa M. (2006). Hippocampal neurons recycle BDNF for activity-dependent secretion and LTP maintenance. EMBO J 25:4372–4380.
   PubMed Web of Science ®Google Scholar
• Scalzo P, Kümmer A, Bretas TL, Cardoso F, Teixeira AL. (2010). Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson’s disease. J Neurol 257:540–545.
   PubMed Web of Science ®Google Scholar
• Schmidt HD, Duman RS. (2010). Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychopharmacology 35:2378–2391.
   PubMed Web of Science ®Google Scholar
• Szeszko PR, Lipsky R, Mentschel C, Robinson D, Gunduz-Bruce H, Sevy S, Ashtari M, Napolitano B, Bilder RM, Kane JM, Goldman D, Malhotra AK. (2005). Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol Psychiatry 10:631–636.
   PubMed Web of Science ®Google Scholar
• Tsukahara T, Takeda M, Shimohama S, Ohara O, Hashimoto N. (1995). Effects of brain-derived neurotrophic factor on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkeys. Neurosurgery 37:733–739; discussion 739–741.
   PubMed Web of Science ®Google Scholar
• Weickert CS, Ligons DL, Romanczyk T, Ungaro G, Hyde TM, Herman MM, Weinberger DR, Kleinman JE. (2005). Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia. Mol Psychiatry 10:637–650.
   PubMed Web of Science ®Google Scholar
• Wong J, Hyde TM, Cassano HL, Deep-Soboslay A, Kleinman JE, Weickert CS. (2010). Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia. Neuroscience 169:1071–1084.
   PubMed Web of Science ®Google Scholar
• Woo NH, Lu B. (2006). Regulation of cortical interneurons by neurotrophins: From development to cognitive disorders. Neuroscientist 12:43–56.
   PubMed Web of Science ®Google Scholar
• Xia YX, Ikeda T, Xia XY, Ikenoue T. (2000). Differential neurotrophin levels in cerebrospinal fluid and their changes during development in newborn rat. Neurosci Lett 280:220–222.
   PubMed Web of Science ®Google Scholar
• Yoshimura R, Umene-Nakano W, Hoshuyama T, Ikenouchi-Sugita A, Hori H, Katsuki A, Hayashi K, Atake K, Nakamura J. (2010). Plasma levels of brain-derived neurotrophic factor and interleukin-6 in patients with dysthymic disorder: Comparison with age- and sex-matched major depressed patients and healthy controls. Hum Psychopharmacol 25:566–569.
   PubMed Web of Science ®Google Scholar